---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-028904"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2023-10-25T23:59:59+00:00"
generated_at: "2026-06-09T09:37:38.660715+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BIO-key Q3 revenue up 33% to $1.8M, net loss per share narrows to ($0.08) from ($0.29)

## Summary
- Revenue $1.8M (+33% YoY); gross profit $1.4M (+43%); gross margin 77% vs 71%.
- Operating loss improved to ~$750K from $2.4M; net loss per share ($0.08) vs ($0.29) in Q3'22.
- Nine-month revenue $6.8M (+30%); net loss reduced to $2.5M from $5.1M in year-ago period.
- ARR ~$7M; secured additional order from international defense ministry customer for expanded rollout.
- Cash and equivalents $0.3M; seeking expense reductions including HQ relocation to reach breakeven.

## SEC filing metadata
- accession: 0001437749-23-028904
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2023-10-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774923028904/0001437749-23-028904-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774923028904/bkyi20231024_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-028904
- JSON: https://secwatch.observer/filing/0001437749-23-028904.json
- Plain text: https://secwatch.observer/filing/0001437749-23-028904.txt

## Key facts
- Earnings Releases
  BIO KEY INTERNATIONAL INC reported three and nine months ended September 30, 2023 results: revenue $1.8M, EPS ($0.08).
  - Period: three and nine months ended September 30, 2023
  - Revenue: $1.8M
  - EPS: ($0.08)
  - Result: preliminary results
  source text: (EXHIBIT 99.1) --- EX-99.1 2 ex_585492.htm EXHIBIT 99.1 ex_585492.htm Exhibit 99.1 Digital Authentication and Identity Provider BIO-key Sees Q3 Revenues Rising over 30% to $1.8M on Strength in Software License Fees, Services and Hardware Sales Holmdel, NJ – October 25, 2023 - BIO-key ® International, Inc. (Nasdaq: BKYI), an innovative provider of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1019034/000143774923028904/0001437749-23-028904-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.